Olive Sensing
Private Company
Total funding raised: $2.5M
Overview
Olive Sensing is pioneering the digitization of home healthcare with its passive toilet-mounted urinalysis sensor, the Olive KG. The device combines advanced optics, IoT, and AI to provide continuous, real-time analysis of urine biomarkers, shifting diagnostics from episodic to continuous monitoring. The company targets the growing market for remote patient monitoring and preventive care, with a vision to make urine a key data source for proactive health management. Its success hinges on clinical validation, regulatory clearance, and consumer adoption of its novel hardware-software platform.
Technology Platform
Toilet-mounted optical sensor combining IoT connectivity and AI analytics for passive, real-time urinalysis.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Olive Sensing appears to be first-to-market with a fully passive, toilet-mounted urinalysis sensor. Competition exists from traditional home urinalysis dipsticks, emerging smart toilet technologies from academic research, and broader remote monitoring platforms from large medtech and digital health companies that may expand into this niche.